Clear Search sequence regions

  • acid (1)
  • cells (3)
  • co (1)
  • humans (1)
  • lutein (15)
  • male (1)
  • plasma (3)
  • rats (4)
  • spleen (1)
  • Sizes of these terms reflect their relevance to your search.

    The aim of the study was to evaluate the ability of poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NP) to enhance lutein bioavailability. The bioavailability of free lutein and PLGA-NP lutein in rats was assessed by determining plasma pharmacokinetics and deposition in selected tissues. Lutein uptake and secretion was also assessed in Caco-2 cells. Compared to free lutein, PLGA-NP increased the maximal plasma concentration (Cmax) and area under the time-concentration curve in rats by 54.5- and 77.6-fold, respectively, while promoting tissue accumulation in the mesenteric fat and spleen. In comparison with micellized lutein, PLGA-NP lutein improved the Cmax in rat plasma by 15.6-fold and in selected tissues by ⩾ 3.8-fold. In contrast, PLGA-NP lutein had a lower uptake and secretion of lutein in Caco-2 cells by 10.0- and 50.5-fold, respectively, compared to micellized lutein. In conclusion, delivery of lutein with polymeric NP may be an approach to improve the bioavailability of lutein in vivo. Copyright © 2015 Elsevier Ltd. All rights reserved.


    Alison Kamil, Donald E Smith, Jeffrey B Blumberg, Carlos Astete, Cristina Sabliov, C-Y Oliver Chen. Bioavailability and biodistribution of nanodelivered lutein. Food chemistry. 2016 Feb 1;192:915-23

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 26304429

    View Full Text